Influencing Public Policy on Research and Clinical Endocrinology
The Endocrine Society produces and signs onto a range of letters to elected officials, Federal agencies, and other legislative and deliberative bodies.
Endocrine Society Comments on Guiding Principles to Apply to Systematic Review in TSCA
August 16, 2018 | In this letter, we encourage the adoption of systematic review approaches in the evaluation of chemicals under the new Toxic Substances Control Act.We also ask EPA to be more specific and transparent in explaining how they will evaluate scientific research for potential harmful effects of chemicals and recommended that EPA develop clearly-defined criteria for expert reviewers, including explicit policies governing conflicts of interest.
Diabetes Advocacy Alliance Comments on USPSTF Research Plan on Abnormal Blood Glucose
August 1, 2018 |The Endocrine Society and members of the Diabetes Advocacy Alliance submitted comments to the U.S. Preventive Services Task Force on its draft research plan to address abnormal blood glucose in Type 2 Diabetes. The comments request the addition of systematic reviews, studies in community-based settings, and interventions for diabetes self-management education and support, among other items, in the research plan.
Endocrine Society Comments on Proposed Title X Changes
July 31, 2018 | The Endocrine Society submitted a letter to Secretary of Health and Human Services Alex Azar to comment on the proposed changes to the Title X funding program which would affect access to care and funding for contraceptive and preventive services for women.
Endocrine Society Supports the Access to Infertility Treatment and Care Act
July 5, 2018 | Unfortunately, many insurance plans do not offer coverage for infertility treatments, cryopreservation, or adoption, leaving those affected to pay the high costs of treatments and/or adoption out-of-pocket. This legislation builds upon existing laws and ensures that all Americans who need and want infertility treatment services have access to them.
Joint Letter Addressing Insulin Pump Denials without Part B Claims
June 20, 2018 | The Endocrine Society, JDRF, AACE, and ADA submitted a letter to Noridian regarding hundreds of denials for insulin pumps when a Part B claim is not present. There are numerous reasons why a Part B claim may exist at the time a pump rental claim is filed and we urge the carrier to reverse the policy which denies these claims.
Endocrine Society Expresses Concerns Over Resolution Limiting Surgeries in Infants with DSD
June 15, 2018 | The Endocrine Society and the Pediatric Endocrine Society co-wrote a letter to California state Senators Scott Wiener, Steve Glazer, and Monique Limón expressing concerns over resolution SCR-110 that would restrict parents’ rights to make decisions regarding surgery for infants born with Differences in Sex Development. Our organizations believe that nuanced, scientific, and evidence-based decision making that is currently part of the process is not reflected in the bill, and therefore does not adequately address the needs of constituencies.
Friends of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD):
June 12, 2018 | Friends of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) requests $39.3 billion for the National Institutes of Health for fiscal year 2019, with a proportional increase in funding for a total of $1.531 billion for NICHD.
Endocrine Society Opposes Proposed Change to National Crime Victimization Survey Related to Gender Identity
May 11, 2018 | The notice proposes to raise the minimum age at which National Crime Victimization Survey questions are administered on sexual orientation and gender identity from age 16 to 18. The Endocrine Society is concerned that the proposed changes to information collection will result in the loss of data on an important subset of the transgender community and provide an incomplete picture of crimes committed against this population. We urge the Administration to continue to collect information on gender identity and sexual orientation from individuals 16 years of age and older.
Endocrine Society Recommends Removal of Medication-Related Products from Tariffs Proposed Rule
May 9, 2018 | The Endocrine Society opposes the application of an additional 25 percent tariff on medications, raw materials used in the production of medications, and medical devices. The Society is concerned that additional tariffs will lead to a shortage of medications as the manufacturers identify alternative sources that are less expensive or an increase in price that could make the cost untenable.
Friends of NIEHS Sign-On Letter in Support of the Superfund Research Program
April 18, 2018 | This letter requests an increase to the Superfund Research Program appropriation of $3 million in the Interior and Environment Appropriations Bill for fiscal year 2019 to a total of $80 million. The letter was organized by the Friends of the National Institute of Environmental Health Sciences.
Representing the Endocrine Society, our members strive to influence public policy related to research and clinical endocrinology issues by testifying before the United States Congress, Federal agencies, and other legislative and deliberative bodies.